HIGH-RISK PROSTATE CANCER
Clinical trials for HIGH-RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immunotherapy combo aims to boost prostate cancer surgery results
Disease control TerminatedThis study was testing a combination of three immunotherapy drugs (N-803, ETBX-071, and M-CENK) given before and after prostate removal surgery in men with high-risk prostate cancer. The goal was to see if this approach could delay cancer return and improve survival. However, the…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New prostate cancer combo therapy trial pulled before it even started
Disease control TerminatedThis study was designed for men with high-risk prostate cancer who cannot have surgery. It planned to test three experimental drugs (N-803, ETBX-071, and M-CENK) given before and after radiation therapy. The goal was to see if the combination could eliminate cancer cells and lowe…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Double-Scan strategy could sharpen prostate cancer staging
Knowledge-focused OngoingThis study looks at whether combining PSMA-PET/CT and MRI scans can more accurately determine the extent of prostate cancer in men with intermediate- or high-risk disease. Researchers will compare the scans to the actual tissue removed during surgery in 600 men across European ce…
Matched conditions: HIGH-RISK PROSTATE CANCER
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC